# The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)

> **NCT01309477** · PHASE3 · COMPLETED · sponsor: **Sun Yat-sen University** · enrollment: 20 (estimated)

## Conditions studied

- Nephrotic Syndrome

## Interventions

- **DRUG:** Tacrolimus Sustained-release Capsules (ADVAGRAF)

## Key facts

- **NCT ID:** NCT01309477
- **Lead sponsor:** Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-01
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2011-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01309477

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01309477, "The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01309477. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*